+44 1223 790975
Accepted Abstracts: Transl Med
This seminar presents case studies on deducing novel Traditional Chinese Medicine (TCM) anti-influenza and anti- hyperlipedemia prescriptions from structure biology and other modern drug discovery technologies. The studies suggest that, by further investigating TCM theory and mining TCM databases, a better drug discovery paradigm may arise. The paradigm can be beneficial to both TCM and modern medicine.
Jun Xu, Professor of Medchem & CADD, School of Pharmaceutical Sciences, and the director and founding Professor of the research center for drug discovery (RCDD) at Sun Yat-Sen University (SYSU) in Guangzhou, China. He is a veteran from America pharmaceutical industry, practicing chemo informatics and computer-aided drug design (CADD) for over 20 years. Recent years, his main focus at SYSU has been to apply the principles of chemo informatics, CADD, and supercomputing technologies to the design of small molecular drugs, and traditional Chinese medicine (TCM) remedies.